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Abstract
Obesity and osteoporosis are closely correlated genetically. FTO gene has been consistently identified to be associated with
obesity phenotypes. A recent study reported that the mice lacking Fto could result in lower bone mineral density (BMD).
Thus, we hypothesize that the FTO gene might be also important for osteoporosis phenotypes. To test for such a
hypothesis, we performed an association analyses to investigate the relationship between SNPs in FTO and BMD at both hip
and spine. A total of 141 SNPs were tested in two independent Chinese populations (818 and 809 unrelated Han subjects,
respectively) and a Caucasian population (2,286 unrelated subjects). Combining the two Chinese samples, we identified 6
SNPs in FTO to be significantly associated with hip BMD after multiple testing adjustments, with the combined P values
ranged from 4.99610
24–1.47610
24. These 6 SNPs are all located at the intron 8 of FTO and in high linkage disequilibrium.
Each copy of the minor allele of each SNP was associated with increased hip BMD values with the effect size (beta) of
,0.025 and ,0.015 in the Chinese sample 1 and 2, respectively. However, none of these 6 SNPs showed significant
association signal in the Caucasian sample, by presenting some extent of ethnic difference. Our findings, together with the
prior biological evidence, suggest that the FTO gene might be a new candidate for BMD variation and osteoporosis in
Chinese populations.
Citation: Guo Y, Liu H, Yang T-L, Li SM, Li SK, et al. (2011) The Fat Mass and Obesity Associated Gene, FTO, Is Also Associated with Osteoporosis Phenotypes. PLoS
ONE 6(11): e27312. doi:10.1371/journal.pone.0027312
Editor: Pieter H. Reitsma, Leiden University Medical Center, The Netherlands
Received June 6, 2011; Accepted October 13, 2011; Published November 18, 2011
Copyright:  2011 Guo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from National Natural Science Foundation of China (81000363, 31000554), the PhD. Programs Foundation of
Ministry of Education of China (20100201120058), the Fundamental Research Funds for the Central Universities, Shanghai Leading Academic Discipline Project
(S30501), and startup funds from University of Shanghai for Science and Technology and Xi’an Jiaotong University. The study was also funded by grants from
National Institutes of Health (NIH R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1 and R21 AA015973) and a SCOR (Specialized Center of
Research) grant (P50 AR055081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yangtielin@xjtu.edu.cn (T-LY); hdeng2@tulane.edu (H-WD)
Introduction
Osteoporosis is a major public health problem with growing
prevalence. Obesity, another common disease, has been demon-
strated to be closely related with osteoporosis [1,2,3]. Adipocytes
and osteoblasts arise from the same progenitor, bone marrow
stromal cells, and can transdifferentiate into each other [4]. With
aging, the composition of bone marrow shifts to favor the presence
of adipocytes, osteoclast activity increases, and osteoblast function
declines, leading to osteoporosis. Moreover, both osteoporosis and
obesity have high genetic predisposition and the genetic
correlation between them have been established across different
ethnic groups [1,3,5]. Previous candidate gene and bivariate
association studies have suggested some common genes both for
obesity and osteoporosis, such as RANK [6], SP7 [7], and SOX6 [8].
Recently, several independent large-scale genome-wide associa-
tion studies (GWAS) consistently identified a gene FTO (fat mass
and obesity associated) to be associated with obesity-related traits
and obesity risk [9,10,11]. The association has been further repli-
cated in multiple studies in different populations [12,13,14,15],
resulting in much increasing attention on this gene. The FTO
protein contains a double-stranded beta-helix fold homologous to
those of Fe(II) and 2-oxoglutarate-dependent oxygenases, which
might be involved in DNA demethylase [16]. Experimental animal
studies provide direct functional evidence that FTO is a causal gene
underlying obesity [17,18]. Interestingly, a recent study found that
the whole body Fto knockout mice displayed immediate postnatal
growth retardation with shorter body length, lower body weight,
and lower bone mineral density (BMD) than controlmice [19]. This
study reminded us that FTO might be a common genetic factor
influencing not only obesity phenotypes, but also osteoporosis
phenotypes, like BMD. To test for such hypothesis, we performed
an association analyses to examine the relationship between the
FTO gene and BMD. Our study was performed in three sample sets
from two ethnicities, including two Chinese Han populations and a
Caucasian population, in order to see whether the variants
identified are common or ethnicity-specific.
Results
The basic characteristics of the study subjects are presented in
Table 1. The major association results for SNPs in FTO with hip
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two Chinese samples, 6 SNPs were identified to be significantly
associated with hip BMD after multiple testing adjustments by
FDR (Table 2). The most significant SNP was rs16952955, with
the P values of 8.39610
24, and 4.31610
22 in the Chinese sample
1 and Chinese sample 2, respectively. After meta-analysis, the
combined P value achieved a significant level of 1.47610
24.
Besides rs16952955, there were 5 additional SNPs (rs2540766,
rs2540784, rs16952951, rs12447427, and rs2689247) showed
significant association signals with hip BMD, with the combined
P values ranged from 4.99610
24–2.95610
24 (Table 2). These 6
SNPs have a consistently protective effect on BMD, since each
copy of the minor allele of each SNP was associated with increased
hip BMD values with the effect size (beta) of ,0.025 and ,0.015
in the Chinese sample 1 and 2, respectively. All of these 6 SNPs
are located at the intron 8 of FTO. We further characterized the
LD for these SNPs using the regional association plot. As shown in
Figure 1, these SNPs were in high LD with the top significant SNP
rs16952955 (pairwise LD r
2.0.9). For the Caucasian sample,
however, no significant results were found for these 6 SNPs and
the MAF of each SNP was quite different between Caucasian
sample and Chinese samples (P,0.01 by x
2 test).
We further performed gender-specific association analyses for
the above 6 SNPs with hip BMD in the Chinese samples. The
association signals in each gender group were generally weaker
than in the total sample, which might be largely due to the smaller
sample sizes in each gender group. The associations were mainly
driven by male subjects as reflected in the Chinese sample 1, with
the P values ranged from 0.012–1.89610
23 (Table 3).
For the spine BMD, 5 of above 6 SNPs achieved significant level
in the Chinese sample 1 (rs16952951: P=8.78610
25; rs16952955:
P=1.47610
24; rs2540784: P=1.97610
24; rs2689247: P=2.116
10
24; rs12447427: P=4.79610
24; and rs2540766: P=1.996
10
23). However, when considering the Chinese samples 1 and 2
together, no SNPs remained significant after FDR adjustments.
For the Caucasian sample, we found another 4 SNPs which are
also located at the intron 8 of FTO to be nominally associated with
spine BMD (rs11076017: P=5.23610
23; rs1420318: P=6.146
10
23; rs1876942: P=7.21610
23; and rs17226942: P=9.23 610
23).
For the previously reported SNP rs9939609 identified by
GWAS for obesity phenotypes [9,10,11], we only detected
nominally significant association with spine BMD in the Chinese
sample 1 (P=0.037).
Discussion
The FTO gene has become the hotspot for researchers since it
was reported as a novel obesity-susceptibility gene by a number of
GWAS and follow-up replication studies. Given the evidence that
obesity and osteoporosis share some common genetic determina-
tions, we first performed an association study examining the SNPs
in FTO for association with BMD. We identified a cluster of SNPs
in FTO to be significantly associated with hip BMD in Chinese
populations.
The human FTO gene is expressed in many tissues including
mesenteric fat, pancreas, liver and adipose tissue, with the highest
concentrations found in the hypothalamus [10,20]. Functional
studies have demonstrated the direct effect of FTO on obesity. For
example, Fischer et al. have reported that the loss of Fto in mice
leads to postnatal growth retardation and a significant reduction in
adipose tissue and lean body mass [18]. Church et al. have shown
that a mutation in the mouse Fto gene results in reduced fat mass,
increased energy expenditure, and unchanged physical activity
[17]. In respect to FTO’s relevance to osteoporosis, a recent study
by Gao et al. has found that Fto plays an essential role in postnatal
growth. The mice lacking Fto completely displayed postnatal
growth retardation manifested as reduced body weight and length,
lower BMD [19]. Taking into account of this biological evidence
and our statistical findings, we suggest that FTO might have
potential role on BMD or osteoporosis.
It is necessary to examine the associations in different
populations from different ethnicities, since the genomic variation
is greater when compared across ethnicities. Our study identified
Table 1. Basic characteristics of the study subjects.
Trait
Chinese
Sample 1
Chinese
Sample 2
Caucasian
Sample 1
Number 818 809 2,286
Female/Male 412/406 413/396 1727/558
Age (years) 28.88 (5.18) 40.18 (16.17) 51.37 (13.76)
Weight (kg) 57.37 (9.83) 62.89 (10.39) 75.27 (17.54)
Height (cm) 163.51 (7.62) 164.99 (8.62) 166.35 (8.47)
BMI (kg/m
2) 21.38 (2.76) 23.06 (3.05) 27.14 (5.75)
Hip BMD (g/cm
2) 0.919 (0.129) 0.921 (0.139) 0.968 (0.175)
Spine BMD (g/cm
2) 0.960 (0.115) 0.935 (0.138) 1.025 (0.157)
Note: Data are shown as mean (standard deviation, SD).
doi:10.1371/journal.pone.0027312.t001
Table 2. Significant association results for SNPs in FTO with hip BMD.
SNP Position
Genic
Position A1/A2 Chinese Sample 1 Chinese Sample 2 Pcombine Caucasian sample
Freq BETA P-value Freq BETA P-value Freq BETA P-value
rs16952955 54099469 Intron8 C/A 0.146 0.0261 8.39610
24 0.132 0.0150 4.31610
22 1.47610
24 0.034 20.0003 9.78610
21
rs2540766 54105971 Intron8 T/C 0.144 0.0236 2.88610
23 0.130 0.0165 3.25610
22 2.95610
24 0.042 20.0042 6.47610
21
rs2540784 54097334 Intron8 G/C 0.146 0.0239 2.38610
23 0.133 0.0159 4.02610
22 3.18610
24 0.035 0.0006 9.52610
21
rs16952951 54099427 Intron8 A/G 0.144 0.0256 1.11610
23 0.132 0.0138 7.56610
22 3.65610
24 0.034 0.0010 9.17610
21
rs12447427 54090589 Intron8 G/A 0.145 0.0241 2.03610
23 0.131 0.0145 6.15610
22 4.57610
24 0.034 0.0005 9.61610
21
rs2689247 54097159 Intron8 A/G 0.147 0.0237 2.42610
23 0.132 0.0145 5.91610
22 4.99610
24 0.035 0.0005 9.56610
21
Freq, frequency is shown for allele A1. Meta-analysis was conducted for Chinese samples 1 and 2 using the METAL software taking into account sample size and
direction of effect (Pcombine). We listed SNPs with Pcombine remaining significant after FDR adjustment.
doi:10.1371/journal.pone.0027312.t002
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in two Chinese populations. Unfortunately, such results were not
replicated in the Caucasian population, which implied some extent
of ethnic difference. Such ethnic difference could be explained
from two aspects. First, the allele frequencies are quite different
between the Chinese and Caucasian populations. The minor
alleles of these 6 significant SNPs were much common in the
Chinese than in the Caucasians, which may contribute to the
overall effect. Second, the difference might be age-specific. The
two Chinese populations were relatively younger than the
Caucasians. Although we have included age as a covariate to
adjust BMD, it could not eliminate the potential confounding
effect of age on BMD variations thoroughly. Since animal studies
have reported that Fto plays an important role in postnatal growth
[19], this might suggest that the FTO gene might be a candidate
genetic marker for peak bone mass acquisition. However, it is still
too early to get the conclusion. We found several other SNPs
which are also in intron 8 of FTO for nominally significant
association with spine BMD in the Caucasian population, but not
in the Chinese populations. Additional studies are needed to
investigate the true effect of FTO on BMD in Caucasian
populations.
The association of FTO with spine BMD was less significant
than with hip BMD in our study, since we only observed
significant associations between FTO and spine BMD in the
Chinese sample 1. When considering the two Chinese samples
together, no SNPs remained significant after multiple testing
adjustments. Our results suggest that the effect of FTO on hip
BMD might be stronger than spine BMD. However, it is still too
soon to get such conclusion. The sample size of the Chinese
samples was relatively small, which might decrease the statistical
power to detect genetic associations. Increasing the sample size in
further studies is needed to validate our results, and we are hopeful
that publication of our findings will facilitate replication analyses
by other groups.
In summary, our data provide novel evidence that a cluster of
SNPs in FTO are associated BMD variations in Chinese
populations. Considering the prior biological findings, we suggest
that FTO might be a new candidate for osteoporosis. Further
studies are warranted to explore the generality of our findings and
elucidate the true functional variant.
Materials and Methods
Subjects
The study was approved by the Institutional Review Board or
Research Administration of Xi’an Jiaotong University, Hunan
Normal University, Creighton University and University of
Missouri-Kansas City. Signed informed consent documents were
obtained from all study participants before entering the study.
Chinese samples. The Chinese sample 1 comprised 818
unrelated subjects, which were recruited from Southwest Chinese
Han adults living in Changsha city and its neighboring areas. The
Chinese sample 2 comprised 809 unrelated subjects drawing from
Northwest Chinese Han adults in Xi’an City and its neighboring
areas. For all the subjects, the exclusion criteria have been detailed
Figure 1. Regional Association Plot for FTO on chromosome 16. The color scheme of a white-to-black gradient reflects lower to higher
linkage disequilibrium (LD, r
2). The r
2 is calculated between the top significant SNP rs16952955 and other SNPs. The scatter graph indicates the
negative logarithm of P value for each SNP, which is based on the combined results in the two Chinese samples.
doi:10.1371/journal.pone.0027312.g001
FTO Gene and BMD
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27312in our earlier publication [21]. Briefly, subjects with chronic
diseases and conditions that might potentially affect bone mass,
structure, or metabolism were excluded from the study to
minimize the influence of known environmental and therapeutic
factors on bone variation. BMD at hip and spine was measured
using Hologic 4500 W machines (Hologic Inc., Bedford, MA,
USA) under the same strict protocols. The coefficient of variation
(CV) values of the dual-energy X-ray absorptionmetry (DXA)
measurements for spine and hip BMDs were approximately 1.01%
and 1.33%, respectively.
Caucasian sample. The Caucasian sample consisted of
2,286 unrelated adults. All of the subjects were US Caucasians
of Northern European origin living in Midwestern area. The
exclusion criteria were the same as with Chinese samples. BMD at
hip and spine were measured using the same model Hologic
4500 W machines (Hologic Inc., Bedford, MA, USA) under the
same strict protocols used in the Chinese sample. The CV values
of the DXA measurements for spine and hip BMDs were
approximately 1.98% and 1.87%, respectively.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using standard protocols. For all the three samples, SNP
genotyping was performed using Genome-Wide Human SNP
Array 6.0 (Affymetrix, Santa Clara, CA, USA), according to the
Affymetrix protocol. Only samples with a minimum call rate of
95% were included. Due to efforts of repeat experiments, all
samples met this criteria and the final mean call rate reached a
high level of 98.93% for Caucasian sample and 98.96% for
Chinese sample. SNPs that deviated from Hardy-Weinberg
equilibrium (HWE, P,0.0001) and had a minor allele frequency
(MAF),0.01 were discarded in each sample set. Thus, 141 SNPs
in FTO were included for subsequent association analyses. The
basic characteristics of these SNPs are summarized in Table S1.
Statistical analyses
Before association analyses, principal component analysis
implemented in EIGENSTRAT [22] was used to adjust for
potential population stratification that may lead to spurious
association results. The first ten principal components emerging
from the EIGENSTRAT analyses, along with sex, age, height,
weight and BMI, were used as covariates to adjust the raw BMD
values in each sample. The residues were used for association
analyses. Linear regression implemented in PLINK [23] was used
to test for association under the additive inheritance model.
Meta-analysisstatisticsweregeneratedusingMETALsoftwarepack-
age (http://genome.sph.umich.edu/wiki/METAL_Documentation)
taking into account sample size and direction of effect. SNAP was
used to characterize linkage disequilibrium (LD) and depict the
regional association plot [24]. A raw P value of ,0.05 in our study
was considered nominally significant, which were further subjected
to a false discovery rate (FDR) of Benjamini and Hochberg pro-
cedure [25] to account for multiple comparisons.
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